Olympia Fields, Illinois Clinical Trials

A listing of Olympia Fields, Illinois clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 41 clinical trials
Phase III Study Assessing the Efficacy Safety and Immunogenicity of SOK583A1 Versus Eylea in Patients With Neovascular Age-related Macular Degeneration

Purpose and rationale: To demonstrate similar efficacy, safety and immunogenicity of SOK583A1 and Eylea EU as per Eylea approved treatment regimen in patients with nAMD. The primary clinical question of interest is: Does SOK583A1 have similar efficacy as Eylea EU in terms of mean change in BCVA score in participants …

Sandoz Investigational Site
 (7.0 away) Contact site
  • 0 views
  • 17 Jul, 2021
  • +37 other locations
Vitamin D3 With Chemotherapy and Bevacizumab in Treating Patients With Advanced or Metastatic Colorectal Cancer

This phase III trial studies how well vitamin D3 given with standard chemotherapy and bevacizumab works in treating patients with colorectal cancer that has spread to other parts of the body. Vitamin D3 helps the body use calcium and phosphorus to make strong bones and teeth. Drugs used in chemotherapy, …

lithium
major surgery
metastatic colorectal cancer
metastatic colorectal adenocarcinoma
folfiri
Ingalls Memorial Hospital
 (6.7 away) Contact site
  • 65 views
  • 27 Jul, 2021
  • +978 other locations
A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight for the Maintenance of Weight Loss

This is a study of tirzepatide in participants with obesity or overweight. The main purpose is to learn more about how tirzepatide maintains body weight loss. The study has two phases: a lead-in phase in which all participants take tirzepatide and a treatment phase in which participants will either continue …

dyslipidemia
body mass index
hypertension
cardiovascular disease
Healthcare Research Network - Chicago
 (1.9 away) Contact site
  • 9 views
  • 30 Jul, 2021
  • +76 other locations
Study to Assess the Efficacy and Safety of Ublituximab + Umbralisib With or Without Bendamustine and Umbralisib Alone in Patients With Previously Treated Non-Hodgkins Lymphoma

Unity NHL - A Phase 2b Randomized Study to Assess the Efficacy and Safety of the Combination of Ublituximab + Umbralisib with or without Bendamustine and Umbralisib alone in Patients with Previously Treated Non-Hodgkin's Lymphoma

b-cell lymphoma
large b-cell lymphoma
acalabrutinib
ibrutinib
umbralisib
TG Therapeutics Investigational Trial Site
 (6.7 away) Contact site
  • 0 views
  • 30 Jul, 2021
  • +203 other locations
Safety and Efficacy of SGN-LIV1A Plus Pembrolizumab for Patients With Locally-Advanced or Metastatic Triple-Negative Breast Cancer

This trial studies ladiratuzumab vedotin (LV) with pembrolizumab in patients with triple-negative breast cancer. It will find out what side effects happen when participants get these two drugs. A side effect is anything the drugs do besides treating cancer. Pembrolizumab is a drug that can be used to treat triple-negative …

stage iv breast cancer
HER2
breast cancer
advanced breast cancer
cancer
Ingalls Cancer Care / Ingalls Memorial Hospital
 (6.7 away) Contact site
  • 179 views
  • 20 Jul, 2021
  • +59 other locations
Efficacy and Safety of Pembrolizumab (MK-3475) With Platinum Doublet Chemotherapy as Neoadjuvant/Adjuvant Therapy for Participants With Resectable Stage II IIIA and Resectable IIIB (T3-4N2) Non-small Cell Lung Cancer (MK-3475-671/KEYNOTE-671)

This trial will evaluate the safety and efficacy of pembrolizumab (MK-3475) in combination with platinum doublet neoadjuvant chemotherapy (NAC) before surgery [neoadjuvant phase], followed by pembrolizumab alone after surgery [adjuvant phase] in participants with resectable stage II, IIIA, and resectable IIIB (T3-4N2) non-small cell lung cancer (NSCLC). The primary hypotheses …

lung carcinoma
mk-3475
pemetrexed
platinum doublet
pembrolizumab
Ingalls Memorial Hospital ( Site 0044)
 (6.7 away) Contact site
  • 551 views
  • 01 Aug, 2021
  • +237 other locations
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

This phase II trial studies nivolumab and ipilimumab in treating patients with rare tumors. Immunotherapy with monoclonal antibodies, such as nivolumab and ipilimumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial enrolls participants for …

bone scan
desmoid tumors
gastrointestinal stromal tumor
gilbert's disease
ovarian cancer
Ingalls Memorial Hospital
 (6.7 away) Contact site
  • 6047 views
  • 01 Aug, 2021
  • +814 other locations
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)

This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.

squamous cell carcinoma
pemetrexed
adjuvant chemotherapy
erlotinib
pembrolizumab
Ingalls Memorial Hospital
 (6.7 away) Contact site
  • 1103 views
  • 01 Aug, 2021
  • +1138 other locations
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors Lymphomas or Multiple Myeloma (The MATCH Screening Trial)

This phase II MATCH trial studies how well treatment that is directed by genetic testing works in patients with solid tumors or lymphomas that have progressed following at least one line of standard treatment or for which no agreed upon treatment approach exists. Genetic tests look at the unique genetic …

treatment regimen
amend
gonadotropin releasing hormone
biomarker analysis
luteinizing hormone
Ingalls Memorial Hospital
 (6.7 away) Contact site
  • 6087 views
  • 01 Aug, 2021
  • +1020 other locations
Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity

The researchers are doing the study to see if semaglutide may reduce the risk of having cardiovascular events in patients with overweight or obesity and with prior cardiovascular disease. The participant will either get semaglutide (active medicine) or placebo ("dummy" medicine). Which treatment the participants get is decided by chance. …

overweight or obesity
body mass index
cardiovascular disease
Novo Nordisk Investigational Site
 (3.9 away) Contact site
  • 7720 views
  • 18 Jul, 2021
  • +1164 other locations